Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoadjuvant Therapy
Interventions: DRUG: Utidelone|DRUG: Carboplatin|DRUG: Epirubicin|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Collaborators: Chinese Academy of Medical Sciences Cancer Hospital，Shanxi Center|Chinese Academy of Medical Sciences Cancer Hospital，Shenzhen Center|First Affiliated Hospital of China Medical University